Luo G, Ducy P, McKee M D, Pinero G J, Loyer E, Behringer R R, Karsenty G
Department of Molecular Genetics, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Nature. 1997 Mar 6;386(6620):78-81. doi: 10.1038/386078a0.
Calcification of the extracellular matrix (ECM) can be physiological or pathological. Physiological calcification occurs in bone when the soft ECM is converted into a rigid material capable of sustaining mechanical force; pathological calcification can occur in arteries and cartilage and other soft tissues. No molecular determinant regulating ECM calcification has yet been identified. A candidate molecule is matrix GLA protein (Mgp), a mineral-binding ECM protein synthesized by vascular smooth-muscle cells and chondrocytes, two cell types that produce an uncalcified ECM. Mice that lack Mgp develop to term but die within two months as a result of arterial calcification which leads to blood-vessel rupture. Chondrocytes that elaborate a typical cartilage matrix can be seen in the affected arteries. Mgp-deficient mice additionally exhibit inappropriate calcification of various cartilages, including the growth plate, which eventually leads to short stature, osteopenia and fractures. These results indicate that ECM calcification must be actively inhibited in soft tissues. To our knowledge, Mgp is the first inhibitor of calcification of arteries and cartilage to be characterized in vivo.
细胞外基质(ECM)的钙化可以是生理性的,也可以是病理性的。生理性钙化发生在骨骼中,此时柔软的ECM会转化为能够承受机械力的坚硬物质;病理性钙化则可发生在动脉、软骨及其他软组织中。目前尚未确定调节ECM钙化的分子决定因素。一个候选分子是基质γ-羧基谷氨酸蛋白(Mgp),它是一种由血管平滑肌细胞和软骨细胞合成的结合矿物质的ECM蛋白,这两种细胞类型可产生未钙化的ECM。缺乏Mgp的小鼠能够足月出生,但会在两个月内死亡,原因是动脉钙化导致血管破裂。在受影响的动脉中可以看到产生典型软骨基质的软骨细胞。缺乏Mgp的小鼠还表现出各种软骨的不适当钙化,包括生长板,最终导致身材矮小、骨质减少和骨折。这些结果表明,软组织中的ECM钙化必须受到积极抑制。据我们所知,Mgp是体内首个被鉴定的动脉和软骨钙化抑制剂。